Atomoxetine Hydrochloride Capsule
Product Images NDC 50268-057

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atomoxetine Hydrochloride (NDC 50268-057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25mg (057 13 25mg)

Atomoxetine is a prescription drug that comes in the form of capsules. Each capsule contains 25 mg of atomoxetine hydrochloride, USP. This medication is recommended to be stored at 20° to 25°C (68 ° to 77 °F) excursions, permitting 15° to 30°C (59 ° to 86 °F) [see USP Controlled Room Temperature]. It is essential to follow the instructions on the package insert carefully. The product must be kept away from children. Pharmacies should provide a medication guide with each prescription. The manufacturer of Atomoxetine capsules is AVKARE, located in Pulaski, TH 38478.*

FDA Label Image

40mg (058 13 40mg)

This is a medication named Atomoxetine, available in the form of capsules that are packed individually in a unit dose of 3x10. The medication is only available with a prescription and needs to be stored between 20 to 25°C. Each capsule contains 40mg of the active ingredient Atomoxetine hydrochloride, USP. The manufacturer of this medication is Avkare, located in Pulaski, TH. The packaging also emphasizes that the enclosed medication guide must be dispersed to each patient, and the usual dosage requirements are mentioned in the package insert.*

FDA Label Image

Atomfig1 (Atomfig1)

FDA Label Image

Atomstructure (Atomstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.